Advanced Imaging

Looking Ahead: What Does the Future Hold for Radioligand Therapy in Prostate Cancer?
A roundtable discussion, moderated by Michael Morris, MD, discussed the current landscape of radioligand therapy in prostate cancer, including recent trial highlights presented at ESMO 2023. Dr. Morris was joined by Tanya Dorff, MD; Evan Yu, MD; and Rana McKay, MD. In the final segment of the roundtable series, the panel shares insights on future advancements in the field, including PSMA-directed Actinium studies and radioligand combination therapy. ...
Advertisement

Latest News

Advertisement

Prostate Cancer Knowledge Hubs

Curated clinical content on prostate cancer types, therapies, and technologies

Prostate Cancer
Prostate Cancer

Conference Coverage

Advertisement
Trending

Advertisement